Zanubrutinib, rituximab and lenalidomide induces deep and durable remission in TP53-mutated B-cell prolymphocytic leukemia: a case report and literature review

Detalles Bibliográficos
Autores principales: Xing, Lijie, He, Qiang, Xie, Linna, Wang, Hui, Li, Zengjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052906/
https://www.ncbi.nlm.nih.gov/pubmed/34937321
http://dx.doi.org/10.3324/haematol.2021.280259

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052906/
https://www.ncbi.nlm.nih.gov/pubmed/34937321
http://dx.doi.org/10.3324/haematol.2021.280259

Ejemplares similares